Literature DB >> 21592985

Identification of human papillomavirus type 58 lineages and the distribution worldwide.

Paul K S Chan1, Alfred C S Luk, Jong-Sup Park, Karen K Smith-McCune, Joel M Palefsky, Ryo Konno, Lucia Giovannelli, Francois Coutlée, Samantha Hibbitts, Tang-Yuan Chu, Wannapa Settheetham-Ishida, María Alejandra Picconi, Annabelle Ferrera, Federico De Marco, Yin-Ling Woo, Tainá Raiol, Patricia Piña-Sánchez, Jo L K Cheung, Jeong-Hoon Bae, Mike Z Chirenje, Tsitsi Magure, Anna-Barbara Moscicki, Alison N Fiander, Rosa Di Stefano, Tak-Hong Cheung, May M Y Yu, Stephen K W Tsui, David Pim, Lawrence Banks.   

Abstract

BACKGROUND: Human papillomavirus type 58 (HPV-58) accounts for a much higher proportion of cervical cancers in East Asia than other types. A classification system of HPV-58, which is essential for molecular epidemiological study, is lacking. METHODS AND
RESULTS: This study analyzed the sequences of 401 isolates collected from 15 countries and cities. The 268 unique concatenated E6-E7-E2-E5-L1-LCR sequences that comprised 57% of the whole HPV-58 genome showed 4 distinct clusters. L1 and LCR produced tree topologies that best resembled the concatenated sequences and thus are the most appropriate surrogate regions for lineage classification. Moreover, short fragments from L1 (nucleotides 6014-6539) and LCR (nucleotides 7257-7429 and 7540-52) were found to contain sequence signatures informative for lineage identification. Lineage A was the most prevalent lineage across all regions. Lineage C was more frequent in Africa than elsewhere, whereas lineage D was more prevalent in Africa than in Asia. Among lineage A variants, sublineage A2 dominated in Africa, the Americas, and Europe, but not in Asia. Sublineage A1, which represents the prototype that originated from a patient with cancer, was rare worldwide except in Asia.
CONCLUSIONS: HPV-58 can be classified into 4 lineages that show some degree of ethnogeographic predilection in distribution. The evolutionary, epidemiological, and pathological characteristics of these lineages warrant further study.

Entities:  

Mesh:

Year:  2011        PMID: 21592985      PMCID: PMC6281402          DOI: 10.1093/infdis/jir157

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  DNA polymerase fidelity and the polymerase chain reaction.

Authors:  K A Eckert; T A Kunkel
Journal:  PCR Methods Appl       Date:  1991-08

2.  Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women.

Authors:  S Huang; I Afonina; B A Miller; A M Beckmann
Journal:  Int J Cancer       Date:  1997-02-07       Impact factor: 7.396

3.  Intratype variation in 12 human papillomavirus types: a worldwide perspective.

Authors:  A C Stewart; A M Eriksson; M M Manos; N Muñoz; F X Bosch; J Peto; C M Wheeler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16.

Authors:  Itzel E Calleja-Macias; Luisa L Villa; Jose C Prado; Mina Kalantari; Bruce Allan; Anna-Lise Williamson; Lap-Ping Chung; Robert J Collins; Rosemary E Zuna; S Terence Dunn; Tang-Yuan Chu; Heather A Cubie; Kate Cuschieri; Magnus von Knebel-Doeberitz; Claudia R Martins; Gloria I Sanchez; F Xavier Bosch; Nubia Munoz; Hans-Ulrich Bernard
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

6.  The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations.

Authors:  L Ho; S Y Chan; R D Burk; B C Das; K Fujinaga; J P Icenogle; T Kahn; N Kiviat; W Lancaster; P Mavromara-Nazos
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential.

Authors:  Dah-Ching Ding; Han-Chuan Hsu; Rui-Lan Huang; Hung-Cheng Lai; Ching-Yu Lin; Mu-Hsien Yu; Tang-Yuan Chu
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-05-27       Impact factor: 2.435

8.  A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping.

Authors:  Tsuyoshi Asato; Toshiyuki Maehama; Yutaka Nagai; Koji Kanazawa; Hiroshi Uezato; Ken-Ichi Kariya
Journal:  J Infect Dis       Date:  2004-04-26       Impact factor: 5.226

9.  Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades.

Authors:  Paul K S Chan; Wendy C S Ho; Mei-Yung Yu; Wai-Mei Pong; Alexander C L Chan; Amanda K C Chan; Tak-Hong Cheung; Martin C S Wong; Ka-Fai To; Ho-Keung Ng
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

10.  Association of human papillomavirus type 58 variant with the risk of cervical cancer.

Authors:  Paul K S Chan; Ching-Wan Lam; Tak-Hong Cheung; William W H Li; Keith W K Lo; May Y M Chan; Jo L K Cheung; Augustine F Cheng
Journal:  J Natl Cancer Inst       Date:  2002-08-21       Impact factor: 13.506

View more
  23 in total

1.  Genetic variability and phylogeny analysis of partial L1 gene of human papillomavirus variants in Buenos Aires, Argentina.

Authors:  Ignacio Javier Chiesa; María Silvia Perez; Guillermo Gabriel Nuñez; Daniel A Pirola
Journal:  Virusdisease       Date:  2015-12-26

2.  Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Rachel L Winer; Constance Mao; Ayaka Hulbert; Shu-Kuang Lee; Zhenping Shen; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

3.  Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas.

Authors:  Mayumi Nakagawa; Horace J Spencer; Hannah N Coleman; William W Greenfield
Journal:  J Ark Med Soc       Date:  2013-01

4.  Follow-up study of HPV58 variants in women with incident HPV58 infection from a Colombian cohort.

Authors:  Mónica Molano; Oscar Buitrago; Pablo Moreno-Acosta; Suzanne M Garland; Nicolás Morales; Antonio Huertas; Teresa Martinez; Oscar Gamboa; Sepehr N Tabrizi; Alyssa Cornall; Nubia Muñoz
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

5.  Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations.

Authors:  Paul K S Chan; Chuqing Zhang; Jong-Sup Park; Karen K Smith-McCune; Joel M Palefsky; Lucia Giovannelli; Francois Coutlée; Samantha Hibbitts; Ryo Konno; Wannapa Settheetham-Ishida; Tang-Yuan Chu; Annabelle Ferrera; María Alejandra Picconi; Federico De Marco; Yin-Ling Woo; Tainá Raiol; Patricia Piña-Sánchez; Jeong-Hoon Bae; Martin C S Wong; Mike Z Chirenje; Tsitsi Magure; Anna-Barbara Moscicki; Alison N Fiander; Giuseppina Capra; Eun Young Ki; Yi Tan; Zigui Chen; Robert D Burk; Martin C W Chan; Tak-Hong Cheung; David Pim; Lawrence Banks
Journal:  Int J Cancer       Date:  2012-11-29       Impact factor: 7.396

6.  Human papillomavirus type 58 genome variations and RNA expression in cervical lesions.

Authors:  Yang Li; Xiaohong Wang; Ting Ni; Fenfen Wang; Weiguo Lu; Jun Zhu; Xing Xie; Zhi-Ming Zheng
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

7.  Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil.

Authors:  Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Medeiros do Amaral; Kamylla Conceição Gomes Nascimento; Lígia Rosa Sales Leal; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

8.  Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Paul K S Chan; Robert D Burk
Journal:  Virology       Date:  2018-01-11       Impact factor: 3.616

9.  Human papillomavirus type 58: the unique role in cervical cancers in East Asia.

Authors:  Paul Ks Chan
Journal:  Cell Biosci       Date:  2012-05-09       Impact factor: 7.133

Review 10.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.